Selon les dernières estimations de l'OMS, on enregistre chaque année dans le monde 498.9 millions de nouveaux cas d'infections sexuellement transmissibles (IST) dont 276.4 millions sont dus au parasite Trichomonas vaginalis (T. vaginalis). Au niveau du tractus génital, la colonisation et l’irritation de la muqueuse vaginale par T. vaginalis favorisent la survenue de complications infectieuses. Ces infections associées peuvent conduire à des infections chroniques et avoir à terme des conséquences graves (stérilité, rupture prématuré du placenta, mort prématurée du nourrisson). De plus, ces infections vaginales représentent des facteurs qui favorisent les infections par le Virus d’Immunodéficience Humaine (VIH-1).A l’heure actuelle, la lutte contre ce type d’infections consiste à agir tant au niveau curatif, que préventif. Ainsi, l’objectif de ce projet est de développer de nouvelles formulations pour la prévention et le traitement des pathogènes qui colonisent les muqueuses vaginales. Dans ce contexte, la formulation que nous proposons est composée de metronidazole inclut dans un hydrogel thermogélifiant à base de pluronic® F127 et de chitosane. Il a été montré que cet hydrogel conserve ces propriétés physiques à une température physiologique même après dilution dans les fluides vaginaux. Ces hydrogels sont stables et permettent une libération prolongée du metronidazole. La formulation n’a montré aucune toxicité envers les cellules HeLa ni envers la muqueuse vaginale porcine. L’efficacité de cette formulation a été prouvée envers T. vaginalis et présente un effet protecteur envers les cellules HeLa en présence de T. vaginalis. L’ensemble des résultats suggère donc la capacité́ de cette formulation à constituer une double barrière, physique et pharmacologique, protectrice de la muqueuse vaginale vis-à-vis de T. vaginalis. / According to the latest WHO estimates, 498 millions of new cases of sexually transmitted infections (STIs) are recorded annually in the world, including 276.4 million due to the parasite Trichomonas vaginalis (T. vaginalis). In the genital tract colonization and irritation of the vaginal mucosa by T. vaginalis promote the occurrence of infectious complications. Associated infections can lead to chronic infections and eventually have serious consequences (infertility, premature placental abruption, premature death). In addition, these vaginal infections can promote infection by Human Immunodeficiency Virus (HIV-1).Currently, the fight against these infections is to act at curative and preventive level. Thus, the objective of this project is to develop new formulations for the prevention and treatment of pathogens that colonize the vaginal mucosa. In this context, we propose a formulation composed of metronidazole and chitosan include in a thermogelling hydrogel of pluronic F127®.It was shown that the hydrogel retains its physical properties even at a physiological temperature and after dilution in the vaginal fluids. These hydrogels are stable and allow a sustained release of the metronidazole. The formulation showed no toxicity against HeLa cells or porcine vaginal mucosa. The effectiveness of this formulation has been proven against T vaginalis and has a protective effect on HeLa cells in the presence of T. vaginalis. The overall results therefore suggest the ability of this formulation to form a double barrier, physical and pharmacological, than protect vaginal mucosa against T. vaginalis.

Les mousses polymères appartiennent à la famille des mousses solides qui sont des matériaux polyvalents, largement utilisés dans un grand nombre d'applications telles que l'automobile, l'emballage, produits de sport, isolants thermiques et acoustiques ou l'ingénierie tissulaire. Composé de bulles d'air piégées dans un réseau continu solide, elles allient les propriétés du polymère avec ceux de la mousse pour créer un matériau intéressant et complexe. L'intégration d'une mousse dans un réseau de polymère permet non seulement d'utiliser la vaste gamme de propriétés intéressantes offertes par les polymères, mais permet aussi de profiter des propriétés avantageuses des mousse telles que la légèreté, la faible densité, la compressibilité et un rapport surface/volume grande surface élevé. En général, les propriétés des mousses polymères sont fortement liées à leur densité et leur structure (la taille des bulles, l’arrangement des bulles dans l’espace, la structure des cellules ouvertes ou fermées). Le contrôle des propriétés finales de ces mousses est donc régi par le contrôle de sa densité et sa structure.Nous avons développé une technique dans laquelle des mousses solides sont générées essentiellement suivant un processus à deux étapes dans lequel une mousse liquide suffisamment stable ayant des propriétés bien contrôlées est générée dans une première étape, puis solidifiée. Avec une telle approche, la production des mousses solides peut être divisé en un certain nombre de sous-tâches qui peuvent être contrôlées et optimisées séparément.Le passage de l'état liquide à l'état solide est essentiellement composé de trois étapes principales: la production de la mousse, le mélange des réactifs et la solidification de la mousse. Ce dernier nécessite l'optimisation de la stabilité de la mousse et des paramètres expérimentaux tels que le choix du temps de moussage et de solidification. En outre, une bonne homogénéité de la mousse polymère appelle à un bon mélange des différents réactifs impliqués dans la formulation de la mousse et de la polymérisation.Une illustration des avantages de cette approche est donnée par la solidification de mousses liquides monodisperses générées à l’aide de la technique millifluidique. Dans une telle mousse, des bulles de volume égal, s’auto-organisent sous l’effet de la gravité et du confinement pour former des structures cristallines. Ainsi, les mousses monodisperses permettent d’avoir un contrôle simultanément sur la taille et la distribution des bulles du matériau poreux final, ce qui donne lieu à une meilleure compréhension de la corrélation entre sa structure et ses propriétés. L’objectif de cette étude est donc d'explorer le nouveau spectre de propriétés, que des mousses polymère offrent lorsque l’on y introduit une structure ordonnée et de démontrer la faisabilité de cette approche à deux étapes pour différentes classes de polymères (hydrogel, polymère super-absorbant et polyuréthane).La génération de ces mousses polymères structurées a été réalisée à l’aide d’un laboratoire sur puce qui permet le rétrécissement des dispositifs expérimentaux à l'échelle micro / millimétrique. Il permet également l’injection et le mélange divers ingrédients liquides et gazeux de la mousse. / Polymer foams belong to the solid foams family which are versatile materials, extensively used for a large number of applications such as automotive, packaging, sport products, thermal and acoustic insulators, tissue engineering or liquid absorbents. Composed of air bubbles entrapped in a continuous solid network, they combine the properties of the polymer with those of the foam to create an intriguing and complex material. Incorporating a foam into a polymer network not only allows one to use the wide range of interesting properties that the polymer offers, but also permits to profit from the advantageous properties of foam including lightness, low density, compressibility and high surface-to-volume ratio. Generally, the properties of polymer foams are strongly related to their density and their structure (bubble size and size distribution, bubble arrangement, open vs closed cells). Having a good control over foam properties is thus achieved by first controlling its density and structure.We developed a technique in which solid foams are generated essentially in a two-step process: a sufficiently stable liquid foam with well-controlled structural properties is generated in a first step, and then solidified in a second one. With such a two-step approach, the generation of solid foams can be divided into a number of well-separated sub-tasks which can be controlled and optimised separately. The transition from liquid to solid state is a sensitive issue of a great importance and therefore needs to be controlled with sufficient accuracy. It is essentially composed of three key steps: foam generation, mixing of reactants and foam solidification and requires the optimisation of foam stability in conjunction with an appropriate choice of both foaming time and solidification time. Furthermore, a good homogeneity of the polymer foam calls for a good mixing of the different reactants involved in the foaming and the polymerisation.A particularly powerful demonstration of the advantages of this approach is given by solidifying monodisperse liquid foams generated using millifluidic technique, in which all bubbles have the same size. In a liquid foam, equal-volume bubbles self-order into periodic, close-packed structures under gravity or confinement. As such, monodisperse foams provide simultaneous control over the size and the organisation of the pores in the final solid with an accuracy which is expected to give rise to a better understanding of the structure-property relationship of porous solids and to the development of new porous materials.We therefore aim to explore the new spectrum of properties, which polymer foams offer when we introduce an ordered structure into them since the most widely used polymer foams nowadays have disordered structures. The goal of our study is to demonstrate the feasibility of this two-step approach for different classes of polymers, including biomolecular hydrogel, superabsorbent polymer and polyurethane.For the generation of the structured polymer foams we use Lab-on-a-Chip technologies which allow the “shrinking” of large-scale set-ups to micro/millimetic scale. It permits also to perform “flow chemistry” in which the various liquid and gaseous ingredients of the foam are injected and mixed in a purpose-designed network of the micro- and millifluidic Lab-on-a-Chip. We adjust this approach according to the requirements of each polymer system, i.e. the foaming and the mixing techniques are chosen to fit the properties of each system, and can be exchanged to fit the properties of the studied systems.

Ces dernières années, les matériaux fonctionnels hybrides ont commencé à être employés pour des applications de la haute technologie, allant des senseurs bio/médicaux, à la production d’énergie renouvelable. Pour cette raison, ils sont devenus le centre de plusieurs études dans le domaine des sciences des matériaux. Simultanément, des molécules conjuguées ont été examinée intensément à cause de leurs propriétés venant de leurs longs systèmes π, allant de la possibilité de conduire l’électricité, à leur capacité d’absorber la lumière dans une grande fenêtre spectrale. Le travail de cette thèse se concentre sur l’introduction de tels systèmes dans deux sortes de matériaux hybrides, les dispositifs photovoltaïques pour la production d’électricité (en particuliers les cellules solaires à pigment photosensible) et de carburants alternatifs (hydrogène), et pour les hydrogels biocompatibles sensibles aux stimuli (capables de conduire l’électricité et de réagir sous irradiation), et sur l’étude de leur influence sur les caractéristiques du matériau final. / In recent years hybrid functional materials began to be employed in a series of technologically advanced applications spanning from bio/medical sensors, to renewable energy generation. For this reason, they became the focus of several studies in the field of materials science. At the same time, conjugated molecules have also been intensively investigated, due to the properties arising by the presence of long π-conjugated systems, from the possibility to conduct electricity to the ability to absorb light in a wide range of wavelengths. This PhD work focused on the introduction of such systems in two different kinds of hybrid materials, namely photovoltaic devices for the production of electricity (in particular Dye Sensitzed Solar Cells) and alternative fuels (hydrogen), and biocompatible stimuli-responsive hydrogels (capable to conduct electricity and to react upon irradiation), and on the study of their influence on the characteristics of the final material.

Wenn erworbene oder angeborene Knochendefekte aufgrund überkritischer Größe oder krankhafter Störungen nicht durch natürliche Regenerationsprozesse geheilt werden können, ist der Einsatz von Knochenersatzmaterialien notwendig. In der vorliegenden Arbeit ist es gelungen ein neuartiges Knochenersatzmaterial zu entwickeln und eingehend zu charakterisieren. Dazu wurden die Phasen Silikat und Kollagen in einem biomimetisch inspirierten Prozess zu einem Anorganik/Organik-Komposit verbunden. Calciumphosphatphasen konnten darüber hinaus als dritte Komponente hinzugefügt werden. Dafür wurden Herstellungsstrategien entwickelt, die Silikat in Form von Kieselsäure, Kollagen als hochkonzentrierte Suspension und gegebenenfalls Calciumphosphat als Pulver zu homogenen Mischungen vereinten. Als Zwischenprodukte wurden Komposithydrogele erhalten, deren Überführung in Xerogele in der Literatur als kritischer Schritt gilt, weil die dabei auftretenden Kapillarspannungen die Gelstruktur in der Regel irreversibel zerstören, wodurch das Material als Pulver oder Fragmente erhalten wird. Im vorliegenden Fall aber konnte die Gelfestigkeit in einem definierten Zusammensetzungsbereich durch die Kompositbildung und die kontrollierte Trocknung der Hydrogele so gesteigert werden, dass monolithische Proben von bis zu mehreren Kubikzentimetern Größe erhalten wurden. Diese konnten ohne weitere Verarbeitungsschritte einer Reihe von Untersuchungen zu mechanischen Eigenschaften, Bioaktivität, Degradabilität und Biokompatibilität unterzogen werden.

No description available.

Bone is a remarkable multifunctional tissue with the ability to regenerate and remodel without generating any scar tissue. However, bone loss due to injury or diseases can be a great challenge and affect the patient significantly. Transplanting bone graft from one site in the patient to the site of fracture or bone void, i.e. autologous bone grafting is commonly used throughout the world. The transplanted bone not only fills voids, but is also bone inductive, housing the particular cells that are needed for bone regeneration. Nevertheless, a regenerative complement to autograft is of great interest and importance because the benefits from an off-the-shelf product with as good of healing capacity as autograft will circumvent most of the drawbacks with autograft. With a regenerative-medicine approach, the use of biomaterials loaded with bioactive molecules can avoid donor site morbidity and the problem of limited volume of material. Two such regenerative products that utilize bone morphogenetic protein 7 and 2 have been used for more than a decade in the clinic. However, some severe side effects have been reported, such as severe swelling due to inflammation and ectopic bone formation. Additionally, the products require open surgery, use of supra physiological doses of the BMPs due to poor localization and retention of the growth factors. The purpose of this thesis was to harness the strong inductive capability of the BMP-2 by optimizing the carrier of this bioactive protein, thereby minimizing the side effects that are associated with the clinical products and facilitating safe and localized bone regeneration at the desired site. We focused on an injectable hyaluronan-based carrier. The strategy was to use the body’s own regenerative pathway to stimulate and enhance bone healing in a manner similar to the natural bone-healing process. The hyaluronan-based carrier has a similar composition to the natural extracellular matrix and is degraded by resident hyaluronidase enzymes. Earlier studies have shown a more controlled release and improved mechanical properties when adding a weight of 25 percent of hydroxyapatite, a calcium phosphate that constitutes the inorganic part of the bone matrix. In Paper I, the aim was to improve the carrier by adding other forms of calcium phosphate. The results indicated that the bone formation was enhanced when using nano-sized hydroxyapatite. We wished to further develop the carrier system but were lacking an animal model with high output and easy access. We also wanted to provide paired data and were committed to the 3 Rs of refinement, reduction and replacement. To meet these challenges, we developed and refined an animal model, and this is described in Paper II. In Paper III, we characterized and optimized the handling properties of the carrier. In Paper IV, we discovered the importance of crushing the material, thus enhancing permeability and enlarging the surface area. In Paper V, we sought to further optimize biomaterial properties of the hydrogel through covalently bonding of bisphosphonates to the hyaluronan hydrogel. The results demonstrated exceptional retention of the growth factor BMP-2. In Paper VI, the in vivo response related to the release of the growth factor was examined by combining a SPECT/PET/µCT imaging method to visualize both the retention of the drug, and the in-vivo response in terms of mineralization.

Un traumatisme de la moelle épinière (TME) est une condition dévastatrice entraînant la perte permanente de fonctions neuronales. L’objectif de cette thèse est de formuler de microsupports pharmacologiquement actif (MPAs) avec une surface de fibronectine (FN), libérant le« brain-derived neurotrophic factor » (BDNF) de façon controlée. Nous voulons combiner ce système avec des cellules souches mésenchymateuses (CSMs) pour la réparation de TME. Le BDNF nanoprécipité a été encapsulé dans les FN-MPAs et le profil de libération in vitro a été évaluée. Elle a montré une libération biphasique et prolongée de BDNF bioactifs. Nous avons combinés des cellules souches humaines mésenchymateuse issues de la moelle osseuse adulte (cellules MIAMI) et FN-MPAs avec un hydrogel non-toxique silanisés-hydroxypropylméthylcellulose (Si-HPMC). Nous avons démontré que les FN-MPAs et le Si-HPMC augmentait l'expression de marqueurs neuraux/neuronaux de cellules MIAMI après 1 semaine. En outre, l'environnement 3D (hydrogel ou FN-MPAs) a augmenté le sécrétome thérapeutique de cellules MIAMI. Pour avoir un système facile à appliquer en clinique, nous avons choisi d’utiliser les cellules souches de la papille apicale (SCAP) et FN-MPAs libérant ou non du BDNF pour la thérapie du TME. Plus de 90 % du SCAP complexée avec FN-MPAs (libérant ou pas BDNF) demeurent viables pendant 7 jours et il y a augmentation de l'expression des gènes neuronaux/oligodendrogliaux in vitro. La récupération de la fonction locomotrice a été significativement améliorée après la transplantation du SCAP complexée avec FN-MPAs-BDNF avec une coordination cohérente du membre postérieur après 28 jours de traitement. / Traumatic spinal cord injury (SCI) is a devastating condition resulting in permanent loss of neural functions. The objective of this thesis is to develop pharmacologically active microcarriers (PAMs) with a fibronectin (FN) surface that deliver biologically active brain derived neurotrophic factor (BDNF) in a controlled manner. We want to combine this system with adult mesenchymal stem cells (MSCs) for SCI repair. The nanoprecipitated BDNF was encapsulated in FN-PAMs and the in vitro release profile was evaluated. It showed a prolonged, bi-phasic, release of bioactive BDNF, without burst effect. We combined human marrow-isolated adult multilineage-inducible (MIAMI) stem cells and FN-PAMs with an injectable non-toxic silanized-hydroxypropylmethylcellulose (Si-HPMC) hydrogel. We demonstrated that FN-PAMs and the Si-HPMC hydrogel increased the expression of neural/neuronal differentiation markers of MIAMI cells after 1 week. Moreover, the 3D environment (FN-PAMs or hydrogel) enhanced the therapeutic MIAMI cell secretome. To have a clinically translatable system, we chose to use stem cells of the apical papilla (SCAP) and FNPAMs releasing or not BDNF for SCI therapy. More than 90% of SCAP complexed with FN-PAMs (releasing or not BDNF) remained viable for 7 days and an increased neuronal-oligodendroglial gene expression in vitro. The recovery of locomotor function was significantly improved after transplantation of SCAP complexed with FN-PAMs-BDNF with frequent to consistent forelimb-hindlimb coordination after 28 days of treatment.

Chapter 1: Introduction to the luminescent properties of lanthanides Luminescence properties of trivalent lanthanides have been explored extensively over the past few decades owing to their unique properties. Lanthanides emission is known to be due to intra-configurational f-f transitions. Because the partially filled 4f shell is well shielded from its 26 environment by the closed 5sand 5pshells, the ligands in the first and second coordination sphere perturb the electronic configurations of the trivalent lanthanide ions only to a very limited extent. This leads to interesting properties such as long lifetimes, sharp line-like emissions etc. which in turn make lanthanides very attractive choice for commercial optical applications. Despite this, the scope of applications remained limited because of the low molar extinction coefficient values of the forbidden lanthanide f-f transitions. However, this problem has been successfully addressed by complexing the lanthanide ion with suitable ligands which can sensitize it resulting in a significant increase in the emission intensity (so called “antenna effect”). The strategy worked very well and resulted in widespread applications of lanthanides form biology to optoelectronics. This chapter discusses elementary ideas regarding the mechanism of sensitization and relevant examples that traces various applications of such lanthanide complexes from the current literature. Chapter 2: A self-assembled Europium Cholate hydrogel: a novel approach towards lanthanide sensitization Luminescent lanthanides can be of great value in a number of possible applications but their scope is limited by their intrinsic low molar absorptivities. Though this problem can be circumvented by complexing the lanthanide ion with suitable chelating ligands to improve the luminescence properties drastically, the design of such systems often involves meticulous planning and laborious synthetic steps to obtain a ligand suitable for the job. It is therefore desirable to have a simpler version of a sensitizing system that does not require the complexities of a chelating ligand but can sensitize trivalent lanthanides with comparable efficiency. It was observed in our group that divalent metal ions (Ni2+, Zn2+, Cu2+, Coetc.) form hydrogels on addition of sodium cholate. We extended to obtain hydrogels of trivalent lanthanides. Furthermore, when the gel was doped with pyrene, a ten-fold increase in the intensity of Eu(III) emission was observed (Fig 2). Thus we established a unique way to sensitize lanthanides in a hydrogel media by non-coordinating chromophores. The approach was completely modular in nature and avoids any laborious synthesis. We also tried other derivatives of pyrene as sensitizers and found that 1-pyreneboronic acid also caused similar sensitization of Eu(III). Fig 2. (a) Schematic representation of the sensitization process (the arrangement of molecules in the gel fiber is arbitrary). Eu-cholate (5 mM/15 mM) gel (a) normal light and (b) 354 nm UV excitation in the presence of 6 μM pyrene Further studies revealed, that 2,3-dihydroxynapthalene (DHN) can sensitize Tb(III) in a similar hydrogel. We also demonstrated Tb(III) to Eu(III) energy transfer process occurring in the gel when doped with DHN. This allowed us to achieve a hydrogel system with tunable luminescence properties (by varying relative ratios of Tb(III) and Eu(III) ). When the effect of divalent metal ions on such energy transfer processes were explored, it was observed that the luminescence from the composite gel of Tb(III)/ Eu(III) is tunable by Zn(II) and through proper manipulation of concentrations one can obtain white light emitting gel (Fig 3). Fig 3. Effect of Zn(II) (from left to right 0 mM, 2.8 mM, 11.3 mM) on Tb3+ (4.5 mM)/Eu3+ (0.11mM)/ sodium cholate (13.6 mM) gels. b) Tb/Eu/Zn-cholate gel (Tb3+ (4.4 mM), Eu3+ (0.11 mM), Zn2+ (7.4 mM), NaC (13.6 mM, DHN 0.2 mM) under 365 nm UV lamp (c) CIE 1931 diagram depicting the luminescence as white (black spot). Chapter 3. A “Pro-Sensitizer” based Sensing of Enzymes using Tb(III) Luminescence in a Hydrogel matrix This chapter descirbes design and realisation of a sensor system based on Tb(III) luminescnece for the detection of enzymes. The idea involved synthesizing a covalently modified DHN molecule by attaching appropriate enzyme cleavable units. We coined the term “pro-sensitizer”to describe the modified molecule which would not sensitize Tb(III) in the gel matrix but when proper enzymes are applied the free form of DHN would be released triggering a luminescence response from Tb(III). This would enable us to monitor the acitivities of the particular enzyme by examining the luminescence intensity enhancement with time (Fig 4) Fig 4. A “pro-sensitizer” based approach to detect different types of enzymes in a hydrogel matrix through Tb(III) luminescence. We applied the idea to develop a novel luminogenic gel probe for inexpensive and rapid detection of three different hydrolases, lipase, β–glucosidase and α-chymotrypsin. The corresponding “pro-sensitizer”for each enzyme were synthesized (Fig 5).The sensing technique depends on the gel matrix to provide the nessesary platform for lanthanide sensitization. Thereofore, it enjoys an edge over the contemporary techniques that typically involve specially designed and synthesized multidentate chelating ligands for this purpose. We also determined important kinetic parameters of all the enzymes, thus enabling us to have a better insight into the activity of the enzymes in the hydrogel matrix. Fig 4. Pro-sensitizers molecules for (1) lipase, (2) β-glucosidase and (3)α-chymotrypsin Chapter 4. A novel approach towards templated synthesis of lanthanide trifluoride nanoparticles Nanomaterials with excellent optical properties have been of special interest. Lanthanide derived nanoparticles, owing to their unique physical properties, provide an excellent choice for applications such as biolabels, lasers, optical amplifiers, and optical-display phosphors. Several types of lanthanide nanoparticles or nanocrystals are reported in the literature such as Nd2O3, Eu2O3, Gd2O3, Tb2O3, and Y2O3. Among them lanthanide fluoride nanoparticles have emerged as the best choice because of their low phonon energy, and thus minimum quenching of emissive Lnions thereby allowing maximum efficiency for several optical applications. In previous literature precedence, LnF3 nanoparticles were typically synthesized following conventional approaches which necessitate use of high temperatures, high pressures (hydrothermal techniques) and capping ligands. In this chapter, we demonstrated a simpler synthesis of LnF3 nanoparticles at ambient temperatures without the requirement of added capping agents. The room temperature synthesis of LnF3 was unprecedented and was achieved simply by diffusing NaF solution through the hydrogels of corresponding Ln-cholate gels. The nanoparticles were characterized by transmission electron microscopy (TEM) and by powder XRD analysis which established the presence of very small (3-4 nm) nanoparticles mono-dispersed uniformly over the the gel matrix (Fig 6). The LnF3 containing xerogels of Tb(III) and Eu(III) cholate gels were also shown to be highly emissive. Fig 6. HRTEM images of a) TbF3, b) GdF3, c) NdF3 and d) DyF3 in their corresponding gel media.

Actuellement, la presbytie peut être corrigée chirurgicalement à l’aide d’implants intraoculaires réfractifs ou diffractifs multifocaux (chirurgie endoculaire invasive et irréversible) ou en intracornéen avec une correction multifocale réfractive (correction laser irréversible, ou insertion d’un implant dans le stroma). L’objectif de ce travail est de développer un nouvel implant permettant de corriger la presbytie, qui allie l’innocuité et la réversibilité d’une correction intracornéenne, à l’efficacité du diffractif. Le design des profils optiques bifocaux a été permis grâce au développement d’outils de simulation optique. Les efficacités de diffraction sont calculées à partir de la propagation du champ électrique par spectre angulaire. La qualité optique est déterminée d’après les simulations de Fonction de Transfert de Modulation obtenues sous Zemax. Des simulations de rendu d’images permettent de visualiser les effets de différents profils envisagés. Les paramètres critiques du design optique sont déterminés. Le choix du matériau dépend des contraintes de biocompatibilité de l’implant et des techniques de fabrication. La solution retenue est un hydrogel à forte teneur en eau, couplé à une nouvelle architecture de l’implant. L’hydrogel est obtenu par polymérisation radicalaire de macromonomères difonctionnels de poly(éthylène glycol) de masses molaires de l’ordre de 8000 g.mol‐1 qui conduisent à des propriétés mécaniques et une perméabilité aux nutriments compatibles avec l’application. La réalisation, la stérilisation et la caractérisation optique de prototypes ont abouti à la preuve du concept d’un implant bifocal diffractif intracornéen / Presbyopia can be corrected with surgery by means of refractive or diffractive multifocal intraocular lenses (which imply an irreversible and invasive endocular surgery) or by intracorneal multifocal refractive correction (irreversible laser correction, or insertion of an intrastromal implant). This work aims at developing a new implant to correct presbyopia, which takes advantage of both the harmlessness and the reversibility of an intracorneal correction, and the efficiency of diffractive optics. The design of the bifocal optical profiles was based on the development of optical simulation tools. The diffractive efficiencies are calculated from the distribution of the electric field with the method of angular spectrum. The optical quality is determined according to the simulations of Modulation Transfer Function obtained with Zemax. Images simulations show the effects of the different profiles studied. The critical parameters of the optical design are also determined. The choice of the material depends on several constraints such as biocompatibility and techniques of manufacturing. The adopted solution relies on the used of an hydrogel with high water content and the design of a new implant architecture. The hydrogel is obtained by radical polymerization of difunctional macromonomers of poly(ethylene glycol) with molar masses around 8000 g.mol‐1, allowing mechanical properties and permeability to nutriments compatible with the application. The realization, the sterilization and the characterization of prototypes showed the proof of the concept of a diffractive bifocal intracorneal implant

Bone fractures and pathologic conditions like chronic wounds significantly reduce the quality of life for the patients, which is especially dramatic in an elderly population with considerable multi-morbidity and lead to substantial socio-economic costs. To improve the wound healing capacity of these patients, new strategies for the design of novel multi-functional biomaterials are required: they should be able to decrease extensive pathologic tissue degradation and specifically control angiogenesis in damaged vascularized tissues like bone and skin. Glycosaminoglycans (GAGs) like hyaluronan (HA) and chondroitin sulfate (CS) as important extracellular matrix (ECM) components are involved in several biological processes such as matrix remodeling and growth factor signaling, either by directly influencing the cellular response or by interacting with mediator proteins. This could be useful in functionalizing biomaterials, but native sulfated GAGs (sGAGs) show a high batch-to-batch variability and are limited in their availability. Chemically modified HA and CS derivatives with much more defined characteristics regarding their carbohydrate backbone, sulfate group distribution and sulfation degree are favorable to study the structure-function relationship of GAGs in their interaction with mediator proteins and/or cells and this might be used to precisely modulate activity profiles to stimulate wound healing. By combining collagen type I as the main structural protein of the bone and skin ECM with these GAG derivatives, 2.5-dimensional (2.5D) and 3D artificial ECM (aECM) coatings and hydrogels were developed. These biomaterials as well as the respective GAG derivatives alone were compared to native GAGs and used to analyze how the sulfation degree, pattern and carbohydrate backbone of GAGs influence: i) the activity of tissue inhibitor of metalloproteinase-3 (TIMP-3) and vascular endothelial growth factor-A (VEGF-A) as main regulators of ECM remodeling and angiogenesis, ii) the composition and characteristics of the developed 2.5D and 3D aECMs, iii) the enzymatic degradation of collagen-based aECMs and HA/collagen-based hydrogels, iv) the proliferation and functional morphology of endothelial cells. Surface plasmon resonance (SPR) and enzyme linked immunosorbent assay (ELISA) binding studies revealed that sulfated HA (sHA) derivatives interact with TIMP-3 and VEGF-A in a sulfation-dependent manner. sHA showed an enhanced interplay with these proteins compared to native GAGs like heparin (HEP) or CS, suggesting a further impact of the carbohydrate backbone and sulfation pattern. sGAGs alone were weak modulators of the matrix metalloproteinase-1 and -2 (MMP-1 and -2) activity and did not interfere with the inhibitory potential of TIMP-3 against these proteinases during enzyme kinetic analyses. However, the formation of TIMP 3/GAG complexes reduced the binding of TIMP-3 to cluster II and IV of its endocytic receptor low-density lipoprotein receptor-related protein-1 (LRP-1, mediates the up-take and degradation of TIMP-3 from the extracellular environment) in a sulfation- and GAG type-dependent manner. It is of note that the determined complex stabilities of TIMP-3 with cluster II and IV were almost identical indicating for the first time that both clusters contribute to the TIMP-3 binding. Competitive SPR experiments demonstrated that GAG polysaccharides interfere stronger with the TIMP 3/LRP-1 interplay than GAG oligosaccharides. The importance of the position of sulfation is highlighted by the finding that a sHA tetrasaccharide exclusively sulfated at the C6 position of the N-acetylglucosamine residues significantly blocked the receptor binding, while CS and HEP hexasaccharides had no detectable effects. Thus, sHA derivatives as part of biomaterials could be used to sequester and accumulate TIMP 3 in aECMs in a defined manner where sHA-bound TIMP-3 could decrease the matrix breakdown by potentially restoring the MMP/TIMP balance. GAG binding might extend the beneficial presence of TIMP-3 into wounds characterized by excessive pathologic tissue degradation (e.g. chronic wounds, osteoarthritis). Mediator protein interaction studies with sHA coated surfaces showed the simultaneous binding of TIMP-3 and VEGF-A, even though the sHA/VEGF-A interplay was preferred. Moreover, kinetic analysis revealed almost comparable affinities of both proteins for VEGF receptor-2 (VEGFR-2), explaining their competition that mainly regulates the activation of endothelial cells. Additional SPR measurements demonstrated that the binding of sGAGs to TIMP-3 or VEGF-A decreases the binding of the respective mediator protein to VEGFR-2. Likewise, a sulfation-dependent reduction of the binding signal was observed after pre-incubation of a mixture of TIMP-3 and VEGF-A with sGAG poly- and oligosaccharides. The biological consequences of GAGs interfering with VEGF-A/VEGFR-2 and TIMP-3/VEGFR 2 were assessed in vitro using porcine aortic endothelial cells stably transfected with VEGFR 2 (PAE/KDR cells). The presence of sHA both decreased VEGF-A activity and the activity of TIMP-3 to inhibit the VEGF-A-induced VEGFR-2 phosphorylation. The same decreased activities could be observed for the migration of endothelial cells. However, if sHA, TIMP-3 and VEGF-A were present simultaneously, sHA partially restored the TIMP-3-mediated blocking of VEGF-A activity. These findings provide novel insights into the regulatory potential of sHA during endothelial cell activation as an important aspect of angiogenesis, which could be translated into the design of biomaterials to treat abnormal angiogenesis. These sHA-containing materials might control the angiogenic response by modulating the activity of TIMP 3 and VEGF-A. The in vitro fibrillogenesis of collagen type I in the presence of sHA derivatives led to 2.5D collagen-based aECM coatings with stable collagen contents and GAG contents that resemble the organic part of the bone ECM. A burst release of GAGs was observed during the first hour of incubation in buffer with the GAG content remaining almost constant afterwards, implying that the number of GAG-binding sites of collagen restricts the amounts of associated GAGs. Moreover, two differently sulfated HA derivatives could for the first time be incorporated into one multi-GAG aECM as verified via agarose gel electrophoresis and fluorescence measurements. This illustrates the multiple options to modify the aECM composition and thereby potentially their functionality. Atomic force microscopy showed that the presence of sHA derivatives during fibrillogenesis significantly reduced the resulting fibril diameter in a concentration- and sulfation-dependent manner, indicating an interference of the GAGs with the self-assembly of collagen monomers. In line with enzyme kinetic results, none of the GAGs as part of aECMs altered the enzymatic collagen degradation via a bacterial collagenase. Thus aECMs were proven to be biodegradable independent from their composition, which is favorable concerning a potential biomedical usage of the aECMs e.g. as implant coatings. HA/collagen-based hydrogels containing fibrillar collagen embedded into a network of crosslinked HA and sGAGs were developed as 3D aECMs. Scanning electron microscopy demonstrated a porous structure of the gels after lyophilization, which could favor the cultivation of cells. The presence of collagen markedly enhanced the stability of the gels against the enzymatic degradation via hyaluronidase, something beneficial to clinical use as this is often limited by the generally fast breakdown of HA. Binding and release experiments with lysozyme, as positively charged model protein for e.g. pro-inflammatory cytokines, and VEGF A revealed that the sulfation of GAGs increased the protein binding capacity for pure GAG coatings and retarded the protein release from hydrogels compared to hydrogels without sGAGs. Moreover, the additional acrylation of sHA was shown to strongly reduce the interaction with both proteins when the primary hydroxyl groups were targets of acrylation. This stresses the influence of the substitution pattern on the protein binding properties of the GAG derivatives. However, hydrogel characteristics like the elastic modulus remained unaffected. The different interaction profiles of lysozyme and VEGF-A with GAGs demonstrated a protein-specific preference of different monosaccharide compositions, suggesting that the mediator protein binding could be simultaneously adjusted for several proteins by combining different GAG derivatives. This might allow the scavenging of pro-inflammatory cytokines and at the same time a binding and release of wound healing stimulating growth factors. Since there is a growing demand for biomaterials to regenerate injured vascularized tissues like bone and skin, endothelial cells were used to examine the direct effects of solute GAGs and hydrogels containing these GAGs in vitro. In both cases, sHA strongly enhanced the proliferation of PAE/KDR cells. A VEGFR-2-mediated effect of GAGs on endothelial cells as underlying mechanism is unlikely since GAGs alone did not bind to VEGFR-2 and had no influence on VEGFR-2 phosphorylation. Other factors like GAG-induced alterations of cell-matrix interactions and cell signaling could be responsible. In accordance with SPR results, a decreased endothelial cell proliferation stimulating activity of VEGF-A was observed in the presence of solute GAGs or after binding to hydrogels compared to the respective treatment without VEGF-A. However, tube formation could be observed in the presence of solute VEGF A and GAGs and within hydrogels with sGAGs that released sufficient VEGF-A amounts over time. Overall the presence of GAGs and VEGF-A strongly promoted the endothelial cell proliferation compared to the treatment with GAGs or VEGF-A alone. Thus, HA/collagen-based hydrogels functionalized with sHA derivatives offer a promising option for the design of “intelligent” biomaterials that direct and regulate the cellular behavior instead of simply acting as inert filling material. They could be used for the controlled delivery and/or scavenging of multiple mediator proteins, thus enhancing the local availability or reducing the activity of these GAG-interacting mediator proteins, or by directly influencing the cellular response. This might be applied to a range of pathological conditions by tuning the biomaterial compositions to patient-specific needs. However, extensive in vivo validation is required to show whether these in vitro findings could be used to control the biological activity of for instance TIMP-3 and VEGF-A, especially under the pathological conditions of extended matrix degradation and dysregulated angiogenesis.